Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
3.
J Cardiothorac Surg ; 10: 105, 2015 Jul 30.
Article in English | MEDLINE | ID: mdl-26223448

ABSTRACT

BACKGROUND: Candida prosthetic endocarditis (CPE) is an uncommon disease involving less than 1 % of infective endocarditis patients and associated with high recurrence rate. Immunosuppresion, intravenous drug abuse, cardiac surgery and indwelling foreign bodies are the major risk factors for CPE. There are very few reported cases of CPE where more than one surgery was performed and there has generally been limited follow up on these cases. CASE PRESENTATION: We report a case of a 35 year old woman who had mitral valve annuloplasty complicated by recurrent episodes of CPE leading to multiple mitral valve replacements (MVR). She underwent MVR surgeries a total of four times over an eighteen year period and had good functionality during most of this time while being on antifungal suppressive treatment. This is a unique case in terms of numbers of surgeries performed, the length of the follow up and the involvement of three different Candida species. CONCLUSION: Current guidelines for the treatment of candida endocarditis recommend surgical treatment followed by long term antifungal therapy although the cure rate by all treatments is low. However we feel that based on this one case it is reasonable to consider multiple redo valve replacement surgeries in conjunction with antifungal treatment for selected patients stable enough to tolerate the surgery.


Subject(s)
Antifungal Agents/therapeutic use , Candidiasis/therapy , Endocarditis, Bacterial/therapy , Heart Valve Prosthesis Implantation/methods , Prosthesis-Related Infections/therapy , Adult , Candidiasis/diagnosis , Candidiasis/microbiology , Endocarditis, Bacterial/diagnosis , Endocarditis, Bacterial/microbiology , Female , Humans , Prosthesis-Related Infections/diagnosis , Prosthesis-Related Infections/microbiology , Recurrence
5.
J Electrocardiol ; 45(6): 741-5, 2012.
Article in English | MEDLINE | ID: mdl-22985610

ABSTRACT

BACKGROUND: Atrial fibrillation occurs in 20% to 40% of patients post cardiac surgery. Prophylactic amiodarone decreases the incidence of atrial fibrillation, especially in those not taking ß-blockers. Studies, however, vary in dosage, duration of treatment, and route of administration. Limited studies evaluating short duration use of oral amiodarone show conflicting results. We hypothesize that an order set for use of short duration, oral amiodarone started the night before surgery and continued for 4 to 6 days will decrease atrial fibrillation after heart surgery. METHODS: The Society of Thoracic Surgeons database was used to identify 471 patients who received amiodarone per order set and 151 patients that did not receive amiodarone. The amiodarone order set included amiodarone 600 mg the night before surgery and 400mg twice daily for 4 to 6 days post heart surgery. After propensity matching, 112 patients remained in each group. We compared outcomes for the 2 groups as a case-controlled, retrospective, study. RESULTS: Atrial fibrillation occurred in 43% (48 of 112) of the patients that did not receive amiodarone vs 23% (26 of 112) receiving prophylactic amiodarone (P=<.001). There was no increased incidence of hemodynamic, pulmonary, or other adverse outcomes observed between the 2 groups. CONCLUSIONS: This practical order set for, short duration, oral amiodarone, with or without adjunct ß-blocker therapy started the night before heart surgery and continued for up to six days post surgery, appears to be a safe and effective treatment for reducing the incidence of atrial fibrillation following heart surgery.


Subject(s)
Amiodarone/administration & dosage , Atrial Fibrillation/epidemiology , Atrial Fibrillation/prevention & control , Cardiac Surgical Procedures/statistics & numerical data , Postoperative Complications/epidemiology , Postoperative Complications/prevention & control , Premedication/statistics & numerical data , Administration, Oral , Female , Humans , Male , Middle Aged , Postoperative Complications/diagnosis , Prevalence , Risk Factors , Treatment Outcome , West Virginia/epidemiology
6.
Am J Cardiol ; 110(12): 1861-3, 2012 Dec 15.
Article in English | MEDLINE | ID: mdl-22980965

ABSTRACT

A 62-year-old man with a history of 2 previous cardiac catheterizations presented with an itchy, nontender skin lesion over his right scapula. The skin lesion had been present for >5 years. Review of the medical records found evidence of a prolonged and complicated cardiac catheterization 8 years previously. Physical examination revealed an 8 × 6 cm, well-demarcated, erythematous reticulated atrophic plaque with telangiectasias and ulceration. Biopsy confirmed histologic changes consistent with radiation dermatitis. In conclusion, the characteristic histologic findings of radiation dermatitis, along with the location over the right scapula and the history of prolonged fluoroscopic exposure during cardiac catheterization, led to the clinical diagnosis of fluoroscopy-induced chronic radiation dermatitis.


Subject(s)
Cardiac Catheterization/adverse effects , Fluoroscopy/adverse effects , Radiodermatitis/etiology , Humans , Male , Middle Aged , Radiodermatitis/pathology
10.
Appl Opt ; 41(27): 5668-71, 2002 Sep 20.
Article in English | MEDLINE | ID: mdl-12269567

ABSTRACT

A coherence theory describing the formation of a hologram by an interesting new technique is presented to improve the theoretical treatment given by Schilling and Templeton [Appl. Opt. 40, 5474 (2001)]. Properties of the hologram pattern are discussed, and some comments are made on its reconstruction.

SELECTION OF CITATIONS
SEARCH DETAIL
...